RE: ASPET Makes Accepted Manuscripts Freely Accessible

["RAPPAZ Francois" <francois.rappaz@unifr.ch>]

And what about the fast forward articles that have been published in the
past issues of these journals, will they be also freely accessible ? I
tried a few tests but was unable to get the full text.

Fran�ois Rappaz

Centre de documentation de la Facult� des Sciences 
Universit� de Fribourg
DokPe - Dokumentationszentrum der Naturwissenschaftlichen Fakult�t Universit�t 
Freiburg 
P�rolles CH-1700 Fribourg Switzerland
http://www.unifr.ch/dokpe/
Tel.: 41 (0)26 300 92 60 
Fax.: 41 (0)26 300 97 30


> -----Original Message-----
> [mailto:owner-liblicense-l@lists.yale.edu] On Behalf Of Rich Dodenhoff
> Sent: vendredi, 29. avril 2005 00:32
> To: liblicense-l@lists.yale.edu
> Subject: ASPET Makes Accepted Manuscripts Freely Accessible
> 
> Effective April 28, 2005, manuscripts accepted for publication in the
> primary-research journals of The American Society for Pharmacology and
> Experimental Therapeutics will be freely accessible to all.  The Journal
> of Pharmacology and Experimental Therapeutics, Molecular Pharmacology,
> and Drug Metabolism and Disposition publish manuscripts online upon
> acceptance as "Fast Forward" articles:
> 
> http://jpet.aspetjournals.org/
> http://molpharm.aspetjournals.org/
> http://dmd.aspetjournals.org/
> 
> For all current and future "Fast Forward" articles, the final manuscript
> version will remain freely accessible after the fully formatted and
> copyedited version is put online.  ASPET will continue to make all of
> its journals' content freely available 12 months after publication.
> 
> ASPET's Board of Publications Trustees has also modified each of the
> journal's Authorship Responsibility, Financial Disclosure, and Copyright
> Transfer form to let NIH-funded authors deposit their accepted
> manuscripts with PubMed Central and to make them freely accessible there
> after 12 months.  ASPET asks NIH-funded authors to abide by this embargo
> period for the PubMed Central site because the articles will be freely
> accessible immediately via the journals.  All "Fast Forward" articles
> are indexed in PubMed and other indexing services, so they are easily
> found.
> 
> The changes implemented by ASPET meet the NIH's goals of providing
> greater public access to research and of allowing the NIH to better
> track the results of its funding.  At the same time, the changes will
> contribute to the continued viability of ASPET and its journals while
> providing free access to all research articles published in ASPET's
> journals.
> 
> Rich Dodenhoff, Journals Director
> American Society for Pharmacology and
>   Experimental Therapeutics
> 9650 Rockville Pike
> Bethesda, MD 20814-3995
> 301.634.7997 (p) / 301.634.7061 (f)